相关实验视频

Updated: Jun 19, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

针对AMPK/Nrf2途径:一种针对急性肺损伤的新型治疗方法

Qianxia Huang¹, Yingcong Ren¹, Ping Yuan¹

¹Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi City, Gui Zhou, People's Republic of China.

Journal of inflammation research

|July 25, 2024

概括

AMP激活蛋白激酶 (AMPK) 和核因子红色素2相关因子2 (Nrf2) 信号显示出治疗急性肺损伤 (ALI) 的前景. 通过化合物激活这种途径可能为肺部保护提供新的治疗策略.

科学领域:

生物化学生化学
细胞生物学细胞生物学
肺部医学肺部医学

背景情况:

急性肺损伤 (ALI) 是由氧化应激驱动的严重呼吸功能障碍,可能会发展为危及生命的急性呼吸困扰综合征 (ARDS).
目前对ALI病因的理解尚不完整,有效的治疗方法有限.
AMP激活蛋白激酶 (AMPK) 调节细胞能量和氧化应激,而核因素红色素2相关因子2 (Nrf2) 则对抗炎症和氧化损伤.

研究的目的:

审查AMPK/Nrf2信号通路在ALI中的作用.
要总结激活AMPK/Nrf2以减轻肺损伤的天然化合物和药物.
为早期ALI干预和肺部保护研究提供参考.

主要方法:

对ALI中AMPK/Nrf2信号传导研究的文献综述.
对针对AMPK/Nrf2通路的化合物和药物的分析.
综合关于肺损伤治疗潜力的研究结果.

主要成果:

AMPK激活促进Nrf2核转位,增强抗氧化基因表达.
这种机制抑制了肺部的炎症反应,对ALI至关重要.
各种天然化合物和药物已在激活AMPK/Nrf2以保护肺部方面表现出有效性.

结论:

AMPK/Nrf2通路是ALI发病的关键调节者,也是一个有前途的治疗标.
激活AMPK/Nrf2为开发针对ALI和ARDS的新疗法提供了一个可行的策略.
对AMPK/Nrf2激活剂的进一步研究可能会导致对肺损伤的有效干预.

关键词:

这就是AMPKK.Nrf2 没有任何问题.肺部急性肺损伤是什么炎症反应是一种炎症反应.氧化应激是一种氧化应激.

更多相关视频

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model

In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model

Published on: November 17, 2018

相关概念视频

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...